Deutsche Bank’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Deutsche Bank’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,300	Closed	-$242K	–	5703
2019 Q1	$242K	Buy	+9,300	New	+$174K	﹤0.01%	3893
2018 Q1	–	Sell	-100	Closed	-$1K	–	5749
2017 Q4	$1K	Sell	100 -7,000	-99%	-$117K	﹤0.01%	4963
2017 Q3	$119K	Buy	+7,100	New	+$116K	﹤0.01%	4110

Deutsche Bank's CMTA Position: Q2 2019 in Review

Deutsche Bank sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 9,300 shares — an estimated $242K sold.

Deutsche Bank first reported a position in CMTA in Q3 2017 and held it in 3 quarters. The position peaked at $242K in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Deutsche Bank reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Deutsche Bank sold 9,300 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $242K.
Deutsche Bank first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 3 quarters.
Deutsche Bank's Clementia Pharmaceuticals Inc. position peaked at $242K in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.